The changing face of health care

Coping with Methuselah: The Impact of Molecular Biology on Medicine and Society

Volumn , Issue , 2004, Pages 105-125

  Garber, Alan M ^a   Goldman, Dana P ^b  

^a STANFORD UNIVERSITY   (United States)

^b RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905217680     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (29)

1. Arrow, Kenneth J. 1963. "Uncertainty and the Welfare Economics of Medical Care." American Economic Review 53 (5): 941-73.
2. Baker, Laurence C. 2001. "Managed Care and Technology Adoption in Health Care: Evidence from Magnetic Resonance Imaging." Journal of Health Economics 20 (3): 395-421.
3. Baker, Laurence C., and Susan K. Wheeler. 1998. "Managed Care and Technology Diffusion: The Case of MRI." Health Affairs 17 (5): 195-207.
4. Bergthold, Linda. 1995. "Medical Necessity: Do We Need It?" Health Affairs 14 (4): 180-90.
5. Collins, Rory, and Stephen MacMahon. 1994. "Blood Pressure, Antihypertensive Drug Treatment, and the Risks of Stroke and of Coronary Heart Disease." British Medical Bulletin 50 (2): 272-98.
6. DCCTRG (Diabetes Control and Complications Trial Research Group). 1993. "The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus." New England Journal of Medicine 329 (14): 977-86
7. DCCTRG (Diabetes Control and Complications Trial Research Group). 1995. "The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy." Annals of Internal Medicine 122 (8): 561-68.
8. DCCT/EDICRG (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group). 2000. "Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy." New England Journal of Medicine 342 (6): 381-89.
9. Escarce, José J., et al. 1995. "Falling Cholecystectomy Thresholds since the Introduction of Laparoscopic Cholecystectomy." Journal of the American Medical Association 273 (20): 1581-85.
10. Fuchs, Victor R. 1974. Who Shall Live? Health, Economics, and Social Choice. Basic Books.
11. Garber, Alan M. 2001. "Evidence-Based Coverage Policy." Health Affairs 20 (5): 62-82.
12. Goldman, Dana, and James Smith. 2002. "Can Patient Self-Management Help Explain the SES Health Gradient?" Proceedings of the National Academy of Sciences USA 99 (16): 10929-34.
13. Hunink, Maria G. 1997. "The Recent Decline in Mortality from Coronary Heart Disease, 1980-1990. The Effect of Secular Trends in Risk Factors and Treatment." Journal of the American Medical Association 277 (7): 535-42.
14. Joyce, Geoffrey F., et al. 2002. "Employer Drug Benefit Plans and Spending on Prescription Drugs." Journal of the American Medical Association 288 (14): 1733-39.
15. Lakdawalla, Darius J., Dana Goldman, and Jay Bhattacharya. 2001. "Are the Young Becoming More Disabled?" Cambridge, Mass.: National Bureau of Economic Research.
16. Manton, Kenneth G., and Xi Liang Gu. 2001. "Changes in the Prevalence of Chronic Disability in the United States Black and Nonblack Population above Age 65 from 1982 to 1999." Proceedings of the National Academy of Sciences USA 98 (11): 6354-59.
17. Manton, Kenneth G., et al. 1997. "Chronic Disability Trends in Elderly United States Populations: 1982-1994." Proceedings of the National Academy of Sciences USA 94 (6): 2593-98.
18. Mills, Robert J., and Shailesh Bhandari. 2003. Health Insurance Coverage in the United States: 2002. Current Population Report (U.S. Census Bureau). September.
19. Newhouse, Joseph P. 1992. "Medical Care Costs: How Much Welfare Loss?" Journal of Economic Perspectives 6 (3): 3-21.
20. Newhouse, Joseph P. 1993. Free for All? Lessons from the Rand Health Insurance Experiment. Harvard University Press.
21. Pauly, Mark V. 1968. "The Economics of Moral Hazard." American Economic Review 58 (3): 531-37.
22. Schwartz, William B. 1987. "The Inevitable Failure of Current Cost-Containment Strategies: Why They Can Provide Only Temporary Relief." Journal of the American Medical Association 257 (2): 220-24.
23. Seidman, Andrew D., et al. 2001. "Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer with Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification." Journal of Clinical Oncology 19 (10): 2587-95.
24. Singer, Burton H., and Kenneth G. Manton. 1998. "The Effects of Health Changes on Projections of Health Service Needs for the Elderly Population of the United States." Proceedings of the National Academy of Sciences USA 95 (26): 15618-22.
25. Slamon, D. J., et al. 2001. "Use of Chemotherapy Plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer that Overexpresses HER2." New England Journal of Medicine 344 (11): 783-92.
26. UKPDSG (UK Prospective Diabetes Study Group). 1998a. "Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33)." Lancet 352 (9131): 837-53.
27. UKPDSG (UK Prospective Diabetes Study Group). 1998b. "Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 38." British Medical Journal 317 (7160): 703-13.
28. Weisbrod, Burton A. 1991. "The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment." Journal of Economic Literature 29 (2): 523-52.
29. Yusuf, Salim P., et al. 2000. "Effects of an Angiotensin-Converting Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients: The Heart Outcomes Prevention Evaluation Study Investigators." New England Journal of Medicine 342 (3): 145-53.